Breast Cancer - Focusing Tumor Microenvironment, Stem Cells and Metastasis 2011
DOI: 10.5772/23005
|View full text |Cite
|
Sign up to set email alerts
|

Remarks in Successful Cellular Investigations for Fighting Breast Cancer Using Novel Synthetic Compounds

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

2
8
0
1

Year Published

2018
2018
2024
2024

Publication Types

Select...
4
1
1

Relationship

0
6

Authors

Journals

citations
Cited by 11 publications
(11 citation statements)
references
References 41 publications
2
8
0
1
Order By: Relevance
“…Cell proliferation assay was first performed on MCF7 and MDA-MB-231 cells, confirming the higher proliferation of the latter, in agreement with the literature (Figure 2a) (Gest et al, 2013;H. et al, 2011;Islam & Resat, 2017).…”
Section: Small Extracellular Vesicles Derived From Mda-mb-231 Promote...supporting
confidence: 89%
See 1 more Smart Citation
“…Cell proliferation assay was first performed on MCF7 and MDA-MB-231 cells, confirming the higher proliferation of the latter, in agreement with the literature (Figure 2a) (Gest et al, 2013;H. et al, 2011;Islam & Resat, 2017).…”
Section: Small Extracellular Vesicles Derived From Mda-mb-231 Promote...supporting
confidence: 89%
“…To test such assumption, we examined the effects of small EVs derived from the TNBC MDA-MB-231 breast cancer cells on the stiffness, cytoskeleton organization, nuclear/cellular morphology, and Yap activity of the Luminal A MCF7 breast cancer cells. The two cell lines have been chosen according to their different well-defined metastatic potential: MDA-MB-231 cells are characterized (Islam & Resat, 2017), whereas MCF7 cells are tumorigenic but have low/absent metastatic potential (Gest et al, 2013;H. et al, 2011).…”
Section: Resultsmentioning
confidence: 99%
“…To test such assumption, we examined the effects of small EVs derived from the TNBC MDA-MB-231 breast cancer cells on the stiffness, cytoskeleton organization, nuclear/cellular morphology, and Yap activity of the Luminal A MCF7 breast cancer cells. The two cell lines have been chosen according to their different well-defined metastatic potential: MDA-MB-231 cells are characterized by high proliferation, motility, and metastatic rate (Islam & Resat, 2017), whereas MCF7 cells are tumorigenic but have low/absent metastatic potential (Gest et al, 2013;H. et al, 2011).…”
Section: Resultsmentioning
confidence: 99%
“…A large majority of published in vitro studies focused on breast cancer and/or estrogen receptor biology have used the MCF-7 human breast cancer cell line. MCF-7 is indeed a commonly used breast cancer cell line, proved to be a suitable in vitro model for breast cancer investigations, including those regarding putative anticancer drugs [80]. Since MCF-7 is a poorly-aggressive and non-invasive cell line, normally being considered to have low metastatic potential [81], it results a good cell system to assay chemopreventive potential of chemicals.…”
Section: Discussionmentioning
confidence: 99%